Mark Kalisz
Impact in
-
- Pluripotent Stem Cells Research
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering
- Renal and related cancers
- Congenital heart defects research
Papers in
-
- Pluripotent Stem Cells Research 5
- Epigenetics and DNA Methylation 3
- Advanced biosensing and bioanalysis techniques 1
- Surgery 4
- Pancreatic function and diabetes 2
- Bladder and Urothelial Cancer Treatments 2
- Co-authors
- Jens Høiriis Nielsen (2 shared papers)David M. Kristensen (2 shared papers)Palle Serup (2 shared papers)Hanne Cathrine Bisgaard (2 shared papers)Anne Grete Byskov (2 shared papers)Maria Winzi (1 shared paper)Jonas Ahnfelt‐Rønne (1 shared paper)J Lindner (1 shared paper)
- Journals
- Urologic Oncology Seminars and Original Investigations (1 paper)The EMBO Journal (1 paper)Molecular Human Reproduction (1 paper)Bioinformatics (1 paper)Cell and Tissue Research (1 paper)
- Partner nations
- DenmarkSpainUnited States
In The Last Decade
Mark Kalisz
10 papers receiving 296 citations
Peers
Comparison fields: 5 of 54
- Molecular Biology 212
- Cancer Research 38
- Reproductive Medicine 19
- Oncology 57
- Genetics 56
Countries citing papers authored by Mark Kalisz
This map shows the geographic impact of Mark Kalisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kalisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kalisz more than expected).
Fields of papers citing papers by Mark Kalisz
This network shows the impact of papers produced by Mark Kalisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kalisz. The network helps show where Mark Kalisz may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Kalisz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 65 | |
| 2 | 2005 | 61 | |
| 3 | 2020 | 46 | |
| 4 | 2010 | 31 | |
| 5 | 2007 | 27 | |
| 6 | 2006 | 23 | |
| 7 | 2011 | 22 | |
| 8 | 2017 | 17 | |
| 9 | 2023 | 5 | |
| 10 | 2020 | 1 | |
| 11 | 2022 | 0 |
About Mark Kalisz
Mark Kalisz is a scholar working on Molecular Biology, Surgery, Public Health, Environmental and Occupational Health, Oncology and Genetics, having authored 11 papers that have together received 298 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (5 papers), Reproductive Biology and Fertility (3 papers), Epigenetics and DNA Methylation (3 papers), Pancreatic function and diabetes (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Molecular Biology (212 citations), Cancer Research (38 citations), Reproductive Medicine (19 citations), Oncology (57 citations) and Genetics (56 citations). Mark Kalisz has collaborated with scholars based in Denmark, Spain and United States. Frequent co-authors include Jens Høiriis Nielsen, David M. Kristensen, Palle Serup, Hanne Cathrine Bisgaard, Anne Grete Byskov, Maria Winzi, Jonas Ahnfelt‐Rønne, J Lindner, Rehannah Borup and Charlotte Karlskov Schjerling. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, The EMBO Journal, Molecular Human Reproduction, Bioinformatics and Cell and Tissue Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.